Eiichi Akaho

572 total citations
37 papers, 480 citations indexed

About

Eiichi Akaho is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Eiichi Akaho has authored 37 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in Eiichi Akaho's work include Computational Drug Discovery Methods (6 papers), Pharmacy and Medical Practices (6 papers) and Synthesis and biological activity (5 papers). Eiichi Akaho is often cited by papers focused on Computational Drug Discovery Methods (6 papers), Pharmacy and Medical Practices (6 papers) and Synthesis and biological activity (5 papers). Eiichi Akaho collaborates with scholars based in Japan, United States and Türkiye. Eiichi Akaho's co-authors include Hamed I. Ali, Süreyya Ölgen, Tomohisa Nagamatsu, Yoshinobu Fukumori, Takayuki Fujita, Y. Kawashima, Takehiro Yamagishi, Anwar Hussain, Hitomi Nakayama and Yoshikazu Takeuchi and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Dental Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Eiichi Akaho

36 papers receiving 457 citations

Peers

Countries citing papers authored by Eiichi Akaho

Since Specialization

Citations

This map shows the geographic impact of Eiichi Akaho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiichi Akaho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiichi Akaho more than expected).

Fields of papers citing papers by Eiichi Akaho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiichi Akaho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiichi Akaho. The network helps show where Eiichi Akaho may publish in the future.

Co-authorship network of co-authors of Eiichi Akaho

This figure shows the co-authorship network connecting the top 25 collaborators of Eiichi Akaho. A scholar is included among the top collaborators of Eiichi Akaho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiichi Akaho. Eiichi Akaho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	VSDK: Virtual screening of small molecules using AutoDock Vina on Windows platform 2011 ·Bioinformation ·(unknown), Eiichi Akaho	17
2	A comparative study of AutoDock and PMF scoring performances, and SAR of 2-substituted pyrazolotriazolopyrimidines and 4-substituted pyrazolopyrimidines as potent xanthine oxidase inhibitors 2009 ·Journal of Computer-Aided Molecular Design ·Hamed I. Ali, Takayuki Fujita, Eiichi Akaho, Tomohisa Nagamatsu	41
3	Reduction of Lipophilicity at the Lipophilic Domain of RXR Agonists Enables Production of Subtype Preference: RXRα‐Preferential Agonist Possessing a Sulfonamide Moiety 2007 ·ChemMedChem ·(unknown), Atsushi Takano, (unknown), (unknown), Nobuyasu Matsuura, Makoto Makishima, Hamed I. Ali, Eiichi Akaho, Akihiro Tai, Kenji Sasaki, Hiroki Kakuta	19
4	Antitumor studies – Part 2: Structure–activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase 2007 ·European Journal of Medicinal Chemistry ·Hamed I. Ali, (unknown), Eiichi Akaho, Munetaka Kunishima, Y. Kawashima, Takehiro Yamagishi, (unknown), Tomohisa Nagamatsu	28
5	Analgesic agents without gastric damage: Design and synthesis of structurally simple benzenesulfonanilide-type cyclooxygenase-1-selective inhibitors 2006 ·Bioorganic & Medicinal Chemistry ·Xiaoxia Zheng, Hiroyuki Oda, (unknown), Yukio Sugimoto, Akihiro Tai, Eiichi Akaho, Hamed I. Ali, Toshiyuki Oshiki, Hiroki Kakuta, Kenji Sasaki	30
6	Antitumor studies. Part 1: Design, synthesis, antitumor activity, and AutoDock study of 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides as a new class of antitumor agents 2006 ·Bioorganic & Medicinal Chemistry ·Hamed I. Ali, (unknown), Eiichi Akaho, Hiroto Kambara, Shinji Miura, Hiroyuki Hayakawa, Noriyuki Ashida, Y. Kawashima, Takehiro Yamagishi, (unknown), (unknown), (unknown)	52
7	A Study on Medicinal Plants from Malaysia Focused onAcalypha siamensisOliv.exGage. Isolation and Structure of a New Tetraterpene, Acalyphaser A 2006 ·Chemistry & Biodiversity ·Hiroto Kambara, Takeshi Yamada, (unknown), S. Matsunaga, Reiko Tanaka, Hamed I. Ali, Christophe Wiart, Zamros Yuzadi Mohd Yusof, (unknown), (unknown), (unknown), (unknown), Michael Jay, Munetaka Kunishima, Eiichi Akaho	6
8	Synthesis and anti-tyrosine kinase activity of 3-(substituted-benzylidene)-1, 3-dihydro-indolin derivatives: investigation of their role against p60c-Src receptor tyrosine kinase with the application of receptor docking studies 2005 ·Il Farmaco ·Süreyya Ölgen, Eiichi Akaho, (unknown)	32
9	Comparison of Prescription Reimbursement Methodologies in Japan and the United States 2003 ·Journal of the American Pharmacists Association ·Eiichi Akaho, Eric J. MacLaughlin, Yoshikazu Takeuchi	4
10	An Innovative Classification of, and a New Structure-activity-relationship Approach to Degradation Kinetics of Cephalosporins: An Attempt to Enhance the Therapeutic Activity 2003 ·The Journal of Antibiotics ·Eiichi Akaho, Hitomi Nakayama	14
11	A study of streptomycin blood level information of patients undergoing hemodialysis 2002 ·Biopharmaceutics & Drug Disposition ·Eiichi Akaho, Takashi Maekawa, (unknown), (unknown)	10
12	Synthesis and receptor docking studies of N-substituted indole-2-carboxylic acid esters as a search for COX-2 selective enzyme inhibitors 2001 ·European Journal of Medicinal Chemistry ·Süreyya Ölgen, Eiichi Akaho, (unknown)	30
13	Studies on adsorption characteristics and mechanism of adsorption of chlorhexidine mainly by carbon black 2001 ·Journal of Pharmaceutical Sciences ·Eiichi Akaho, Yoshinobu Fukumori	15
14	A Study on Docking Mode of HIV Protease and Their Inhibitors. 2001 ·Eiichi Akaho, (unknown), David S. Goodsell, David J. Wong, Arthur J. Olson	10
15	A Proposed Optimal Health Care System Based on a Comparative Study Conducted Between Canada and Japan 1998 ·Canadian Journal of Public Health ·Eiichi Akaho, (unknown), (unknown), (unknown), Takashi Okamoto	3
16	Pharmaceutical Care Innovations in Japan 1996 ·Journal of the American Pharmaceutical Association (1996) ·Eiichi Akaho, Edward P. Armstrong, Masami Fujii	2
17	Comparison of manual and online searches of Chemical Abstracts 1986 ·Journal of Chemical Information and Computer Sciences ·Eiichi Akaho, (unknown), (unknown)	1
18	Mechanism of diffusion of compounds through ethylene vinyl acetate copolymers I. Kinetics of diffusion of l-chloro-4-nitrobenzene, 3,4-dimethylphenol and 4-hexylresorcinol 1984 ·International Journal of Pharmaceutics ·Akira Kagayama, (unknown), Eiichi Akaho, (unknown), (unknown), Anwar Hussain	16
19	Selecter System Design for the Iowa Drug Information Service Microfilm File 1982 ·Drug Information Journal ·Eiichi Akaho, (unknown), (unknown), (unknown), (unknown)	2
20	Solubility Behavior of Phenolic Compounds in Hexane—ethyl Acetate, Hexane—ethyl Myristate, and Hexane-Ethyl Pivalate Cosolvent Systems 1981 ·Journal of Pharmaceutical Sciences ·Eiichi Akaho, Katsumi Iga, J. H. Kraal, Anwar Hussain	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact